Heleen Vroman

The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder et al. · Cancer Cell · 2020 · 668 citations · Full text

Life Sciences, Immunology, Oncology +14

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman et al. · Journal for ImmunoTherapy of Cancer · 2020 · 63 citations · Full text

Medicine, Immunology, Oncology +17

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial

Robert A. Belderbos, Rossana Berardi, Robin Cornelissen et al. · Translational Lung Cancer Research · 2019 · 58 citations · Full text

Life Sciences, Immunology, Oncology +17

Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study

Sai Ping Lau, Larissa Klaase, Marianne Vink et al. · European Journal of Cancer · 2022 · 58 citations · Full text

Medicine, Immunology, Oncology +17

TNF-α–induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma

Heleen Vroman, Ingrid M. Bergen, Jennifer A. C. van Hulst et al. · Journal of Allergy and Clinical Immunology · 2017 · 57 citations

Life Sciences, Immunology, Pathology +17